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ABSTRACT

Mycotoxins are ubiquitous, moldproduced toxins that contaminate a wide
variety of foods and feeds. Ingestion of
mycotoxins cause a range of toxic
responses, from acute toxicity to longterm or chronic health disorders. Some
mycotoxins have caused outbreaks of human toxicoses, and at least one
mycotoxin, aflatoxin B1, is a presumed
human hepatocarcinogen. As part of a
comprehensive effort to curtail the adverse health effects posed by mycotoxins, substantial research has been conducted to determine the mechanism of
action of mycotoxins in animals. This
review presents some of the current
knowledge on the biological action of
four diverse classes of mycotoxinsaflatoxin B1, tricothecenes, zearalenone,
and fumonisin B1-with particular emphasis on mechanisms of action.
(Key words: mycotoxin, mold, toxicity,
biological action)

Abbreviation key: AF = aflatoxin (also used
with B1, MI, Q1, and PI), AFB1-FAPyr =
AFB 1-formamidopyrimidine adduct, AFBIW-Gua = AFB1-N7-guanine adduct, AFL =
aflatoxicol (used with HIand MI), ELEM =
equine leukoencephalomalacia, FBI = fumonisin B1, GSH = glutathione, HCC = hepatocellular carcinoma, ZEN = zearalenone, yGT+ =
y-glutamyl-transpeptidase-positive.
INTRODUCTION

Thousands of natural toxins exist that have

Received September 30, 1991.
Accepted June 11, 1992.
‘Supported in pan by National Institutes of Health
grant ES04813. Paper Number 4227 of the Utah Agricultural Experiment Station.
1993 J Dairy Sci 76:880-891

known or potential adverse health effects in
humans and animals. Natural toxins have been
termed “nature’s pesticides” because they often
confer a protective or competitive advantage to
the organism or plant that produces them (2).
Because the diet contains at least 10,000 times
more natural toxins exist compared with synthetic toxins (manmade toxins, such as pesticides or environmental chemicals), natural toxins probably pose the greater threat to human
and animal health (1). One large group of
natural toxins that are nearly universal contaminants of food and feed are the mycotoxins,
the toxic secondary metabolites produced by
fungi.
Mycotoxins are a diverse group of chemicals that elicit a wide range of toxic responses
in animals and humans. h e - or postharvest
contamination of various food crops by
mycotoxigenic fungi is a common problem;
approximately 25% of the world’s food supply
is contaminated by mycotoxins annually (19).
The severity of mycotoxin contamination of
agricultural commodities varies yearly. Excessive moisture in the field and in storage, temperature extremes, humidity, drought, variations in harvesting practices, and insect
infestation are major environmental factors
that determine the severity of mycotoxin contamination. Although the actual resultant economic loss to agriculture is difficult to determine with accuracy, it is likely to be high.
In domestic animals, such as dairy cattle,
swine, and poultry, mycotoxin contamination
reduces growth efficiency, lowers feed conversion and reproductive rates, impairs resistance
to infectious diseases, reduces vaccination efficacy, and induces pathologic damage to the
liver and other organs. Many mycotoxins have
been implicated in outbreaks of human diseases. Some are potent animal, and presumed
human, carcinogens. For these reasons,
mycotoxins pose a major threat to public and
animal health, and determination of the biological mechanism of action of mycotoxins has
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understandably been the focus of much research. The biological action of four classes of
mycotoxins that represent diverse toxicities to
(AF)B 1, tricothecenes,
animals-aflatoxin
zearalenone (ZEN),and fumonisin B1 (FBI)are considered in this overview.
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AFB1

Aflatoxin B1 (Figure 1) represents a group
of mycotoxins produced by strains Aspergillus
jlavus and Aspergillus parasiticus. Of the
known mycotoxins, AFBl had generated the
greatest concern and has stimulated the most
research effort because of its extreme toxicity
and its widespread Occurrence in staple foods
and feeds (such as peanuts, corn, and cottonseed). For these reasons, AFBl currently is the
only mycotoxin that is regulated by the FDA.
In foods, the current “action level” (the concentration above which the commodity is condemned) is 20 ppb of total AF. The action
level for the AFB1 metabolite AFMl in milk is
.5 ppb. Other regulatory guidelines for AFB1
include 20 ppb in corn for dairy cows, 300 ppb
in corn for finishing beef cattle and swine, and
100 ppb for breeding stock (24). The permissible amount of AFB1 in cottonseed for beef
cattle, swine, and poultry is 300 ppb (55).
These regulatory levels generally preclude detectable AFBl in the various products from
these animals. Worldwide, established tolerances for A F B l in animal feeds range from 10
to 600 ppb (65).
Prevention of Aspergillus infection in foods
and feeds is the most desirable method of
reducing AFB1, although AFBl contamination
often is unavoidable, even with the best
agricultural practices. Therefore, several strategies have been developed to reduce postharvest
product contamination of AFB1. Some of these
methods involve early identification and segregation of grossly contaminated kernels of corn
or peanuts or use of electronic devices to identify and to reject grains that exhibit fluorescence that is due to AFB1. Although these
methods have been useful for peanuts, they
have not been practical for decontaminating
corn and cottonseed (54). Ammoniation has
shown considerable promise as a means of
treating contaminated cottonseed and corn because it can be used to treat large batches of
product, and, importantly, ammoniation results
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Figure I . Chemical structure of atlatoxin (AF) AFBl
and DNA adducts of AFBI, AFB1-V-guanine and formamidopyrimidine (AFBI-FAPyr).

in nearly complete elimination of AF and associated toxicity in commodities (54). Ammoniation has not yet achieved FDA approval
for interstate shipments, but it is in use in
some states. Another experimental strategy is
the use of inorganic absorbent feed additives,
which prevent absorption of mycotoxins in
animals. For example, when added to feeds
contaminated by AFB1, hydrated sodium calcium aluminosilicate, an anticaking agent approved by the FDA, significantly reduced bioavailability of AFBl and many of the AFB1specific toxic effects in pigs (14).
A requisite step in the toxic and carcinogenic action of AFBl is its conversion to a
variety of metabolites (Figure 2). Metabolism
of A F B l is mediated principally by hepatic and
extrahepatic microsomal cytochromes P-450,
although other conversions have also been
described (16). Most of the metabolic products
are less toxic than parent AFB1, the most
prevalent of which is AFM1, so named for its
appearance in the milk of dairy cows that
consume feed contaminated by AFB1. Other
detoxified metabolites produced from the P450 oxidation of AFBl include AFQl and
A F P l (Figure 2).
Aflatoxin B1 also is reduced by soluble
NADPH-dependent cytosolic enzymes to produce aflatoxicol (AFL). Because this reaction
is reversible, AFL may be a storage form of
AFBl (56). The chronic and acute toxicity of
Journal of Dairy Science Vol. 76, No. 3. 1993
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Figure 2. Metabolic scheme of aflatoxin B1. The solid lines represent known pathways; the dashed lines signify
presumed or proposed pathways

AFL is equal to that of AFB1; thus, this
metabolite is not considered to be a detoxified
metabolite. Furthermore, the mutagenic
potency of AFL is nearly equal to that of
AFBl (17). Two minor and relatively nontoxic
reduced pentanone metabolites also exist,
AFL-M1 and AFL-HI. The former metabolite
also may be formed by the cytosolic reduction
of AFMl (64).
Aflatoxin B1 also is metabolized by
cytochromes P-450 to the reputed proximate
carcinogen, the AFB 1-8,g-epoxide. Presumably
because of its extreme reactivity, the AFBI8,9-epoxide has been isolated only indirectly
from biological systems as adducts of
glutathione (GSH) or DNA bases. The AFB18,9-epoxide can be inactivated by GSH, a reaction catalyzed by GSH S-transferase. Inactivation by GSH is an important AFBl detoxification pathway in a number of species, and the
formation of AFB1-GSH protects against the
hepatocarcinogenic effects of AFBl (22, 43).
Detoxification mediated by GST may be an
important determinant in species resistance to
AFB1. Aflatoxin B1 also may be detoxified via
Journal of Dairy Science Vol. 76. No. 3. 1993

conjugation with sulfates and glucuronic acid
(11). The AFB1-8,9-epoxide also may be catalytically (by epoxide hydrolase) or spontaneously hydrolyzed to the AFB 1-8,9-dihydrodiol.
The carcinogenic and mutagenic action of
AFBl probably is a result of the affinity of the
electrophilic and highly reactive AFB1-8,9epoxide for cellular nucleophiles, such as
DNA. Activated AFBl binds exclusively to
guanyl residues, and the AFB1-N7-guanine adduct (AFB1-fl-Gua) is the most predominant
(Figure 1). Other adducts have been isolated,
of which the “ring-opened” derivative of
AFB1-N7-Gua, AFB1-formamidopyrimidine
(AFB1-FAPyr), is the most common (Figure
1). In hepatic DNA from livers of rats injected
with AFB1, approximately 80% of the adducts
present are AFB1-N7-Gua, whereas the AF’BIFAPyr constitutes approximately 7% (23). The
formation of these adducts is the presumed
first step in the development of heritable mutations from which tumors may arise. Repair of
these genetic lesions occurs in living cells
enzymatically or spontaneously, and the removed adducts is excreted in the urine.
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The ring-opened adduct appears to be more
resistant to DNA repair enzymes. In rats
treated with a single dose of AFB1, the AFB1N7-Gua was rapidly removed with an apparent
half-life of 7.5 h, whereas other adducts, such
as AFBI-FAPyr, were removed much more
slowly (20).
Alkylation of DNA with AFBl also may
result in the loss of a DNA base, resulting in
an “apurinic site”. In synthetic oligomers
treated with AFB1, at least twice as many
apurinic sites were detected as AFB1-N7-Gua
(13). Which of these genetic lesions ultimately
is responsible for the carcinogenic action of
AFBl is not known. Microsomally activated
AFBl induced GC is converted to TA transversions in a strain of Escherichia coli, presumably as a result of AFBi-N7-Gua formation
(26). In any event, AFB1-specific mutations
also exist in cellular protooncogenes and other
loci in tumors from animals treated with AFB1
(67).
The metabolism of AFJ31, specifically the
balance between activation and detoxification
pathways in an animal, and the formation and
repair of genetic lesions induced by this
mycotoxin appear to be critical determinants of
species sensitivity. Specific relationships have
been derived from a number of comparative
studies in which sensitive species (rat and rainbow trout) have been compared with resistant
species (mouse and salmon) with respect to
endpoints that define these processes. For example, the in vivo binding of AFBl to hepatic
DNA was 40 times greater in the rat than in
the more resistant moslse (45). A likely mechanism underlying the relative resistance of the
mouse is that it efficiently detoxifies the
AFB1-8.9-epoxide via GSH S-transferase (50).
Toxic effects of AFBl are either acute or
chronic, depending in large part on the dose
and duration of exposure. Aflatoxin B1 is
acutely toxic to a number of cell types, plants,
invertebrates, and various vertebrate species.
Cattle, swine, and poultry are the farm animals
primarily affected by AFBI. Common observations 1 to 2 d following acute exposure to
AFBl include malaise, loss of appetite, and
eventually lower growth rates. Because many
of these sequelae are not specific for AF, field
diagnoses often are difficult. Approximately .2
ppm of AFBl causes reduced weight gains in
cattle, swine, and poultry; between 2 and 10
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ppm of AFBl resulted in decreased egg
production, hepatic necrosis, hemorrhage, and
death in poultry (57).
In the bovine, acute AFBl decreased rumen
motility (31). In a review on that subject,
studies were described showing that AFBl
reduced cellulose breakdown and production of
VFA and ammonia either in vivo or in artificial rumen environments (47). Decreases in
feed conversions, breeding efficiency, and milk
production and health problems resulted when
a dairy herd was exposed chronically to corn
contaminated by AF at 120 ppb (31).
The liver is the organ most severely affected by AFBj, and the primary lesions include hemorrhagic necrosis, fatty infiltration,
and bile duct proliferation. In pigs, guinea
pigs, and dogs, these effects most commonly
occur in the centrilobular region, whereas in
ducklings and rats, the periportal region is the
site of action. Acute toxicities for AFBl have
been tabulated extensively (1 1). In vertebrate
species, at least a 10-fold variation occurs in
susceptibility to the acute effects of AFB1, and
no species appear to be totally resistant. Poultry, rainbow trout, and monkeys are particularly sensitive to the acute effects of AFBI;
oral median lethal doses are .34 to .56, 3.0, and
.81 mgkg, respectively. The mouse, hamster,
and rat are much less sensitive; these species
have oral median lethal doses of 9.0, 10.2, and
1.3 mgkg, respectively (56). Significant differences occurred in potency of AFBl in age,
strain, gender, and route of administration.
Aflatoxin B1 is carcinogenic in a wide variety of animals. As is the case following acute
exposures, the major target organ is the liver,
although tumors in other organs result from
long-term dietary exposure to AFB1. Aflatoxin
B1 at .4 ppb fed over 14 mo resulted in a 14%
incidence of hepatocellular carcinomas (HCC)
in rainbow trout, the animal species known to
be most sensitive to the carcinogenic effects of
this mycotoxin (42). By contrast, tumor incidence was only 5% during a similar time in
Fischer rats exposed to 5 ppm of AFBl (83).
Considerable epidemiological data also support the hypothesis that dietary AFBl is an
important risk factor for human HCC. In many
geographical areas where incidence of HCC is
high, such as sub-Saharan Africa and Southeast Asia, a linear relationship exists between
AFBl contamination of food and the incidence
Journal of Dairy Science Vol. 76, No. 3, 1993
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of HCC (78). However, a firm determination
of the role of AFBl in human cancer is confounded by the coincidence of hepatitis B virus
infection, which is another reputed factor for
HCC in humans in these regions. Further confirming evidence on the role of AFBl in HCC
has been obtained through the use of new,
sensitive methods to detect specific “biomarkers” of human exposure to AFB1, such as
adducts of DNA (3, 30), or serum albumin
(63). Measurement of these biomarkers in samples of blood or urine has allowed direct determination of actual AFBl exposure in populations, which is an improvement over random
dietary analysis for AFB1 and imprecise dietary recall surveys. Thus, the use of biomarkers should significantly improve AFBl risk
assessment.
Although the majority of interest in the
possible health effects has correctly focused on
dietary exposure to AFBl,workers in food and
grain production and in harvest, transport, and
processing industries also are exposed to considerable amounts of airborne, respirable grain
dusts contaminated by AFB 1. For example,
airborne dust sampled in a corn processing
plant contained 107 ng/m3 AFB1, and the daily
occupational exposure to this toxin was estimated to be between 40 and 856 ng (10). In
another survey, concentrations of AFB1 in
smaller, more easily retained airborne grain
particles, contained more AFB1 than that in
larger grain particles; AFBl in particles under
7 pm were as high as 1814 ppb, whereas
AFB1, ranging from 7 to 11 pm had an average of 695 ppb (69).
A small number of studies indicate that
exposure to airborne AFBl may adversely affect health of those exposed. For example,
airborne peanut dust contaminated with AFBl
was linked to increases in liver and lung cancer in Dutch peanut processing workers relative to unexposed cohorts (35). An earlier survey established that these workers were
exposed continually to between .04 and 2.5 pg
of AFBl/wk (77). In laboratory studies, AFBl
was converted to stable metabolites and activated to mutagenic and DNA binding intermediates by cells of the mammalian respiratory epithelium (5, 6, 18). In cultured airway
epithelia from a variet of mammalian species,
AFBl forms AFB1-NY-Gua and AFBI-FAPyr
in patterns similar to those in hepatic systems
(6).
Journal of Dairy Science Vol. 76. No. 3. 1993

TRICOTHECENES

Tricothecenes are a group of over 150 structurally related compounds produced by several
genera of fungi, the most important being
Fusarium. Fusarium sporotrichioides and
Fusarium graminearum are the most common
tricothecene producers. In this country,
tricothecenes commonly infect corn grown in
the upper Midwest. Low temperatures, high
moisture, and humidity appear to increase
toxin production. Tricothecenes possess the
tetracyclic 12,13-epoxy-tricothecane skeleton
of the sesquiterpenoids (75). Examples of important tricothecenes include T-2 toxin,
nivalenol, and deoxynivalenol (Figure 3). Of
these compounds, T-2 toxin has been the most
widely studied, because it was one of the first
tricothecenes discovered in grains, although
deoxynivalenol (vomitoxin) is the most common contaminant of cereal grains such as
wheat and barley in many countries worldwide
(74).
The toxic potency of several tricothecenes
in laboratory animals has been tabulated (74,
75). The most acutely toxic tricothecene, verrucarin J, had a median lethal dose of .5 mgkg
i.v. in mice. In mice, toxin T-2 and nivalenol
are nearly equitoxic; median lethal doses are
5.2 and 4.1 mgkg (i.p.), respectively. The in
vivo toxicity of T-2 toxin and nivalenol are
approximately 10 times that of deoxynivalenol.
In a variety of in vitro systems, T-2 consistently has been the most toxic, followed by
nivalenol and then deoxynivalenol (75).
The tricothecenes produce a wide variety of
toxic effects: acute tricothecene toxicity is
characterized by gastrointestinal disturbances,
such as vomiting, diarrhea, and inflammation.
Dermal irritation, feed refusal, abortion, and
hematological sequelae, such as anemia and
leukopenia, also are common. In cattle, dietary
T-2 toxin at .64ppm for 20 d resulted in death
and bloody feces, enteritis, and abomasal and
ruminal ulcers (57). In poultry, as low as 5
ppm of tricothecenes resulted in oral necrosis
and reduced BW gains (12). Egg production
and shell quality were decreased when poultry
were fed a diet of 20 ppm of T-2 toxin (57).
Tricothecenes also are toxic when administered
dermally. Toxic reactions, which were similar
to those observed when the tricothecenes were
administered systematically, were observed
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when applied doses ranged from IO-" mol
(for T-2 toxin, vermcarin A) to lW7 mol
(deoxynivalenol) (75).
Alimentary toxic aleukia, which is the most
common human tricothecene mycotoxicosis,

H

follows a multistage pathogenesis. Shortly after ingestion of contaminated cereal grains, a
burning sensation in the mouth, tongue, throat,
esophagus, and stomach and gastrointestinal
disturbances are the initial observations (66). A
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Figure 3. Chemical structures of T-2toxin, nivalenol, deoxynivalenol, zearalenone, and fumonisin B1. AC = Acetate.
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severe leukopenia and granulopenia may then
follow, which may progress to white cell
counts as low as 100 cells/pI of blood (66).
Continuous exposure to trichothecenes then
results in rashes on the skin, which may progress to severe necrotic lesions.
The actual mechanisms of these toxic actions of the tricothecenes are not clear. Investigators studying the mechanisms of toxicity
thus far have focused on the effects of these
mycotoxins on protein and macromolecular
synthesis, membrane function, and immune
parameters. Ueno et al. (76) initially observed
that a number of tricothecene mycotoxins inhibited protein synthesis in eukaryotic cells.
The toxin inhibited all steps in protein synthesis (initiation, elongation, and termination) in
intact ribosomes (2 1). Structure-activity studies
indicated that the C-4 or C-5 positions or the
isovaleryl group at the C-8 position of T-2
were important for inhibition of protein synthesis in vitro because h s mycotoxin was
more potent than HT-2, neosolaniol, or T-2
tetrol (72). A substituent at the C-3 position to
T-2, such as an acetyl group, making acetyl T2 for example, resulted in a diminution of
inhibition of in vitro protein synthesis. Protein
synthesis inhibition likely is a result of binding
of the toxin to ribosomes. The binding of T-2
to ribosomes is specific and saturable (.3 nM),
and the stoichiometry is one toxin molecule
bound per ribosome (48).
Because T-2 toxin is an amphipathic molecule, it could be incorporated into the lipid or
protein moieties of cellular plasma membranes,
thereby interfering with membrane function
(59). The in vitro treatment of L-6 myoblasts
with 8.5 x 10-12 M T-2 toxin reduced the
uptake of Ca, glucose, Leu, and Tyr within 10
min of exposure (9). These effects were independent of protein synthesis inhibition. Effects were similar for erythrocytes treated with
T-2 but at a much higher concentration (32).
Recently, human fibroblasts exposed to T-2 (1
pLIM) accumulated lucifer yellow dye to the
same extent as control cells, indicating that T-2
had no effect on membrane function, at least
with respect to this indicator (40).
The toxin significantly alters several immune parameters, and the major effects appear
to be associated with the cellular immune response, specifically including inhibition of the
mitogen response, reductions of protein, DNA,
Journal of Dairy Science Vol. 76, No. 3, 1993

and interleukin-2 synthesis in normal spleen
cells treated with concanavalin A (73), thymic
atrophy (60, 74), and reductions in plaqueforming spleen cells (73). In animals, resistance to many challenges that are dependent on
cellular immune-response was decreased, such
as resistance to mycobacterial infections and
skin grafts in mice (37, 61), Salmonella in
mice (71), and aspergillosis in rabbits (52).
The effects of tricothecenes on the immune
system have been reviewed recently (66).
ZEN

Zearalenone is a phenolic resorcyclic acid
lactone (Figure 3) produced by strains of
Fusarium, primarily by F. graminearurn, F.
sporotrichiodes, and others. Zearalenone is a
natural contaminant of corn, wheat, barley,
oats, sorghum, and hay. Toxin production is
promoted by high humidity and low temperatures, as is common in the upper Midwest
during autumn harvest. Zearalenone is a nearly
universal corn contaminant and often occurs in
the same samples with tricothecenes (44). Despite its dissimilarity to steroid compounds,
ZEN produces potent
hyperestrogenic
responses in susceptible animals. Thus, the
toxicity of this compound is unique among
known mycotoxins.
Swine are most affected by ZEN, but other
animals, such as cattle, poultry, and laboratory
animals, are also affected, but to a lesser degree. Symptoms of ZEN poisoning include
uterine enlargement and swollen vulva and
mammae (51). In pigs, symptoms of hyperestrogenism generally appear when contamination of ZEN in corn exceeds 1 ppm, but it can
occur at concentrations as low as .1 ppm (49).
In ewes, ZEN exposure resulted in declines in
ovulation rate and cycle length and an increase
in duration of estrus but did not affect pregnancy rate or embryonic loss (68). Young male
pigs exposed to ZEN undergo symptoms of
“feminization”, such as enlarged nipples and
testicular atrophy (51).
Dairy heifers exposed to ZEN have reduced
conception rates (19). However, transmission
of ZEN or its metabolites into milk appears to
be minimal (58). In rats, decreased growth
rate, food intake, fertility, resorptions, stillbirths, abortion, and bone malformations in
fetuses also are sequelae of ZEN ingestion at
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10 mgkg (4). Egg production in hens is
reduced by ZEN (8).
Zearalenone elicits permanent reproductive
tract alterations. In newborn female mice, ZEN
treatment (1 pg/d for 5 d) resulted in significant ovary-dependent reproductive tract alterations at 8 mo posttreatment: the majority of
treated mice lacked corpus lutea and uterine
glands and exhibited squamous metaplasia of
the uterine luminal epithelium (81). Ovariectomized mice treated with ZEN showed none
of these ovary-dependent alterations.
The mechanisms of the estrogenic effect of
ZEN appears to be mediated via binding of
this mycotoxin or its metabolites to the
cytoplasmic estrogen receptor. Trans- and cisZEN and two ZEN derivatives competed with
17P-estradiol for binding with the cytosolic
receptor in rat uterine tissue (41). In that study,
the binding affinity of ZEN to the receptors
was only .1 that of estradiol. Translocation of
the ZEN receptor complex into immature rat
uterine nuclei induced synthesis of a protein
with identical properties to that following
translocation of natural estrogen receptor (38).
Interestingly, ZEN appears to have a greater
affinity for estrogen receptors from animals
that are more susceptible to the estrogenic
effects of the mycotoxin. The affinity of ZEN
to uterine and oviduct estrogen receptors followed this order: pig, rat, and chicken (25).
FUMONlSlNS

A group of mycotoxins that were discovered recently have been associated with toxicity and mortality in horses and pigs following
ingestion of corn-based feeds that were contaminated by Fusaria. One such animal disease
is the neurotoxic syndrome equine leukoencephalomalacia (ELEM). The ELEM syndrome often is epizootic and almost always is
associated with ingestion of moldy corn. Research on the possible effects of Fusarium
contamination of foods and feeds began in
earnest following initial laboratory studies
showing that
cultures of
Fusarium
monilifomze, the most common fungal contaminant of corn, caused cancer in rats (36).
Shortly thereafter, a group of compounds
named fumonisins were isolated and characterized (7, 27). Fumonisin B1 is the most toxic
representative of the fumonisins (Figure 3).
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Recently, fumonisins have been linked positively to ELEM (39, 46), which is characterized by facial paralysis, nervousness, lameness,
ataxia, and inability to eat or to drink. The
principal pathologic lesions include severe cerebral edema, focal malacia, and liquefaction
of cerebral white matter. The onset of such
severe symptoms can be as short as a few
hours. Fourteen of 18 horses fed a corn-based
feed contaminated with 37 to 122 ppm of FBI
developed fatal ELEM (82). Hepatic involvement often is coincident with central nervous
system involvement in horses and swine. Two
reports also have described the development of
pulmonary edema, hydrothorax, or both in
swine receiving either intravenous injections of
FBI or by ingesting feed contaminated by FBI
(33, 62). In swine, lower doses of FBIresulted
in a slowly progressive hepatic necrosis;
higher doses resulted in acute pulmonary
edema coincident with hepatic toxicity (34).
That fumonisins are potent inhibitors of sphingosine biosynthesis in cultured hepatocytes
(80) has been postulated to account for the
hepatotoxic (34) and central nervous system
effects of this toxin (53). Compared with
-1,
however, FBI is much less toxic to
cultured hepatocytes (29).
Aside from its acute effects, FBI also appears to possess tumor-initiating and tumorpromoting activity. Initial studies showed that
a diet containing culture material inoculated
with F. monilifonne was carcinogenic in rats
(36). In later studies with purified FBI, a
promotional effect on the incidence of
diethylnitrosamine-induced, y-glutamyltranspeptidase-positive (y-GT+) hepatic foci in rats
was noted (27). Short-term dietary FBI induced a high incidence (66%) of HCC (28).
Metastases to the heart, lungs, or kidneys also
were observed. Symptoms of hepatic involvement, such as macronodular cirrhosis and
cholangiofibrosis, also were observed.
In a recent study, Gelderblom et al. (29)
noted that FBI is probably only a modest
initiator of liver tumors, because y-GT+ foci
and hepatocellular nodules were observed only
after prolonged feeding of .l% FBI in rats.
Those authors (29) postulated that the carcinogenic effect of FBI likely involves promotion
and the selection of initiated hepatocytes,
events that occur during the postinitiation
phase of hepatocarcinogenesis.
Journal of Dairy Science Vol. 76, No. 3, 1993
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The mechanism of fumonisin carcinogenic- essential to obtain some understanding of the
ity does not appear to involve interaction with mechanisms underlying sensitivity and resisDNA. Neither FBI nor F B 2 elicited unsche- tance to the carcinogenic effects of this
duled DNA repair in primary rat hepatocyte mycotoxin. Molecular biological approaches
cultures treated either in vitro or in vivo (29). have begun to provide some information on
Therefore, the carcinogenic activity of fumoni- the role of AFBl in mutations in specific
sins may be mediated via epigenetic mechan- cancer-causing genes in humans and other
isms, as is the case of peroxisome prolifera- animals. Mechanism studies on the fumonisins
tors.
will be advanced with the identification of
Research on the health effects of fumonisins appropriate animal models of the toxic effects
has essentially only just begun, and informa- observed in domestic animals.
tion on the mechanism of fumonisin toxicity or
New methods to detect specific biomarkers
on the mechanisms underlying species sensi- in noninvasive samples, such as urine, are
tivity is only beginning to be compiled. More beginning to be an important tool in measureinformation is needed to obtain a fuller under- ment of actual human exposure in populations
standing of the extent of the adverse effects of that are particularly at risk. Biomarkers for
fumonisins in human and animal health. Be- other potentially carcinogenic mycotoxins to
cause corn is a staple in many parts of the which humans are exposed, such as fumoniworld and because Fusarium contamination of sins, will likewise allow greater determination
corn is nearly universal, fumonisins likely are of risk. Identification of potentially synergistic
involved in human toxicoses and other health risk factors coincident with mycotoxin exeffects. Corn contaminated by Fusarium has posure, such as other foodbome toxins, infecbeen epidemiologically associated with human tious agents, and synthetic chemicals, will also
esophageal cancer in some regions of South be important in these efforts.
Africa (70).
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humans who consume foods contaminated by
mycotoxin is of critical concern. Laboratory
and epidemiological approaches are important
in addressing this question. In the case of
AFB1, comparative species studies have been
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